We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.19B
AUM Growth
-$441M
Cap. Flow
-$740M
Cap. Flow %
-23.22%
Top 10 Hldgs %
67.11%
Holding
51
New
7
Increased
9
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$12M
2
MDT icon
Medtronic
MDT
+$11.4M
3
MSFT icon
Microsoft
MSFT
+$11.3M
4
AMGN icon
Amgen
AMGN
+$11.2M
5
DOC icon
Healthpeak Properties
DOC
+$11.2M

Top Sells

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$76.5M
2
HCA icon
HCA Healthcare
HCA
+$64.2M
3
PARA
Paramount Global Class B
PARA
+$62.1M
4
DVA icon
DaVita
DVA
+$50.7M
5
FMC icon
FMC
FMC
+$48.4M

Sector Composition

Rank Sector Weight
1 Healthcare 73.97%
2 Technology 9.8%
3 Consumer Discretionary 6%
4 Materials 4.64%
5 Communication Services 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$21.1B
$484M 15.2%
19,761,353
– –
TAK icon
2
Takeda Pharmaceutical
TAK
$55.7B
$300M 9.4%
16,788,589
+593,279
+4% +$10.8M
BHC icon
3
Bausch Health
BHC
$2.34B
$232M 7.3%
14,957,708
-686,420
-4% -$11.8M
CI icon
4
Cigna
CI
$74.6B
$222M 6.97%
1,310,027
+8,277
+0.6% +$1.46M
HCA icon
5
HCA Healthcare
HCA
$89.5B
$204M 6.41%
1,638,515
-518,694
-24% -$64.2M
MCK icon
6
McKesson
MCK
$101B
$189M 5.92%
1,267,259
+48,555
+4% +$7.37M
DXC icon
7
DXC Technology
DXC
$1.73B
$182M 5.73%
10,218,215
-1,769,815
-15% -$32.3M
LH icon
8
Labcorp
LH
$25.9B
$131M 4.13%
812,986
-41,441
-5% -$6.57M
HOLX
9
DELISTED
Hologic
HOLX
$96.4M 3.03%
1,450,171
-485,564
-25% -$30.7M
PARA
10
DELISTED
Paramount Global Class B
PARA
$96.3M 3.02%
3,439,825
-2,316,959
-40% -$62.1M
MTOR
11
DELISTED
MERITOR, Inc.
MTOR
$81.1M 2.54%
3,871,291
-1,580,189
-29% -$35.6M
NUAN
12
DELISTED
Nuance Communications, Inc.
NUAN
$79.9M 2.51%
2,406,267
-2,635,864
-52% -$76.5M
COR icon
13
Cencora
COR
$61.2B
$79.4M 2.49%
819,674
-135,485
-14% -$13.5M
FMC icon
14
FMC
FMC
$1.33B
$73.6M 2.31%
694,509
-452,610
-39% -$48.4M
IQV icon
15
IQVIA
IQV
$39.3B
$66M 2.07%
418,985
-132,273
-24% -$20.7M
UHS icon
16
Universal Health Services
UHS
$10.5B
$61.6M 1.93%
575,634
-102,518
-15% -$11M
CTVA icon
17
Corteva
CTVA
$51.3B
$48.1M 1.51%
1,670,774
-846,966
-34% -$23.8M
MAR icon
18
Marriott International
MAR
$92.3B
$40.5M 1.27%
437,717
-284,172
-39% -$26.8M
BSX icon
19
Boston Scientific
BSX
$71.5B
$39.9M 1.25%
1,045,052
-1,067,949
-51% -$41.2M
MOH icon
20
Molina Healthcare
MOH
$10.3B
$38.1M 1.2%
208,374
-123,645
-37% -$22.5M
MYGN icon
21
Myriad Genetics
MYGN
$312M
$36M 1.13%
2,757,993
+947,266
+52% +$12M
CAR icon
22
Avis
CAR
$5.02B
$34.8M 1.09%
1,321,354
-954,055
-42% -$28.7M
HUM icon
23
Humana
HUM
$46.2B
$34.4M 1.08%
83,089
-88,243
-52% -$35.5M
BKD icon
24
Brookdale Senior Living
BKD
$3.4B
$32M 1%
12,586,554
-750,000
-6% -$2.07M
EXPE icon
25
Expedia Group
EXPE
$37.3B
$31.7M 0.99%
345,433
+90,384
+35% +$8.13M
1
2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Glenview Capital Management held 51 positions worth $3.19B, down 12% from $3.63B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Glenview Capital Management withdrew a net $740M in Q3 2020, closing 6 positions and reducing 27 holdings. Its most notable exit was UnitedHealth, an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 70% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Glenview Capital Management opened a new position in Medtronic worth $11.8M.

  • Glenview Capital Management's largest Q3 2020 buy was Medtronic: 113,882 shares worth $11.8M.
  • Glenview Capital Management added most to Myriad Genetics in Q3 2020, an estimated $12M increase.
  • Glenview Capital Management's biggest Q3 2020 reduction was Nuance Communications, Inc., cutting an estimated $76.5M.
  • Glenview Capital Management fully exited UnitedHealth in Q3 2020, selling an estimated $32.7M.
  • Glenview Capital Management's ten largest holdings make up 67% of its $3.19B portfolio in Q3 2020.
  • Glenview Capital Management opened 7 new positions and closed 6 in Q3 2020.
  • Glenview Capital Management's portfolio value fell 12% quarter-over-quarter to $3.19B.

Based on Glenview Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.